{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:52:54Z","timestamp":1788382374813,"version":"build-2803163510"},"reference-count":129,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.survophthal.2015.04.003","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T21:47:38Z","timestamp":1431640058000},"page":"524-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review"],"prefix":"10.1016","volume":"60","author":[{"given":"Megan","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice Y.J.T.","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5154-4233","authenticated-orcid":false,"given":"Hongyu","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2015.04.003_bib1","series-title":"Angiogenesis","author":"Adair","year":"2010"},{"key":"10.1016\/j.survophthal.2015.04.003_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/0974-620X.142591","article-title":"Vascular endothelial growth factor trap-eye and trap technology: Aflibercept from bench to bedside","volume":"7","author":"Al-Halafi","year":"2014","journal-title":"Oman J Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib3","series-title":"Shields' Textbook of Glaucoma","first-page":"294","author":"Allingham","year":"2011"},{"key":"10.1016\/j.survophthal.2015.04.003_bib4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/08820530902800959","article-title":"Neovascular glaucoma: a historical perspective on modulating angiogenesis","volume":"24","author":"Anchala","year":"2009","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib5","first-page":"264","article-title":"Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)","volume":"104","author":"Azar","year":"2006","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.survophthal.2015.04.003_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jss.2008.04.023","article-title":"The role of vascular endothelial growth factor in wound healing","volume":"153","author":"Bao","year":"2009","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.survophthal.2015.04.003_bib7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc1093","article-title":"Tumorigenesis and the angiogenic switch","volume":"3","author":"Bergers","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.survophthal.2015.04.003_bib8","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jvs.2010.10.056","article-title":"Inhibition of stromal cell-derived factor-1\u03b1 further impairs diabetic wound healing","volume":"53","author":"Bermudez","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.survophthal.2015.04.003_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/0003-4819-158-4-201302190-00008","article-title":"Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the U.S. Preventive Services Task Force","volume":"158","author":"Boland","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2015.04.003_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","article-title":"Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial","volume":"384","author":"Brose","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2015.04.003_bib11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2147\/OPTH.S7698","article-title":"Bevacizumab (Avastin) for the management of anterior chamber neovascularization and neovascular glaucoma","volume":"3","author":"Brouzas","year":"2009","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib12","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.110.957332","article-title":"Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation","volume":"122","author":"Bry","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.survophthal.2015.04.003_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mvr.2005.10.004","article-title":"Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS","volume":"71","author":"Cai","year":"2006","journal-title":"Microvasc Res"},{"key":"10.1016\/j.survophthal.2015.04.003_bib14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00061198-200306000-00015","article-title":"Morphologic classification of filtering blebs after glaucoma filtration surgery: the Indiana Bleb Appearance Grading Scale","volume":"12","author":"Cantor","year":"2003","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.survophthal.2015.04.003_bib15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm0603-653","article-title":"Angiogenesis in health and disease","volume":"9","author":"Carmeliet","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.survophthal.2015.04.003_bib16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1442-9071.2012.02773.x","article-title":"Definition of glaucoma: clinical and experimental concepts","volume":"40","author":"Casson","year":"2012","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib17","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jamaophthalmol.2014.2356","article-title":"Human ciliary epithelium as a source of synthesis and secretion of vascular endothelial growth factor in neovascular glaucoma","volume":"132","author":"Chalam","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib19","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1517\/17425247.2014.926886","article-title":"RNA interference technology for anti-VEGF treatment","volume":"11","author":"Chen","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.survophthal.2015.04.003_bib20","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1442-9071.2012.02798.x","article-title":"Bleb vascularity following post-trabeculectomy subconjunctival bevacizumab: a pilot study","volume":"40","author":"Chua","year":"2012","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib21","doi-asserted-by":"crossref","first-page":"a017236","DOI":"10.1101\/cshperspect.a017236","article-title":"Clinical characteristics and current treatment of glaucoma","volume":"4","author":"Cohen","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.survophthal.2015.04.003_bib22","first-page":"756","article-title":"TGF-beta1, -beta2, and -beta3 in\u00a0vitro: biphasic effects on Tenon's fibroblast contraction, proliferation, and migration","volume":"41","author":"Cordeiro","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.04.003_bib23","doi-asserted-by":"crossref","first-page":"e39558","DOI":"10.1371\/journal.pone.0039558","article-title":"Vascular endothelial growth factor receptor-3 directly interacts with phosphatidylinositol 3-kinase to regulate lymphangiogenesis","volume":"7","author":"Coso","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.survophthal.2015.04.003_bib24","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2125.2008.03278.x","article-title":"Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma: a survey on 23 cases throughout 12-month follow-up","volume":"66","author":"Costagliola","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/157339909787314149","article-title":"Diabetic retinopathy and angiogenesis","volume":"5","author":"Crawford","year":"2009","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.survophthal.2015.04.003_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1741-7015-4-6","article-title":"What is the global burden of visual impairment?","volume":"4","author":"Dandona","year":"2006","journal-title":"BMC Med"},{"key":"10.1016\/j.survophthal.2015.04.003_bib27","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0161-6420(03)00103-9","article-title":"Long-term results of noncontact neodymium:yttrium-aluminum-garnet cyclophotocoagulation in neovascular glaucoma","volume":"110","author":"Delgado","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2015.04.003_bib28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1442-9071.2008.01716.x","article-title":"Risk factors for first presentation of glaucoma with significant visual field loss","volume":"36","author":"Deva","year":"2008","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/IJG.0b013e318170a747","article-title":"Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients","volume":"18","author":"Duch","year":"2009","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.survophthal.2015.04.003_bib30","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/IAE.0b013e3181679c0b","article-title":"Combination intravitreal bevacizumab\/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma","volume":"28","author":"Ehlers","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2015.04.003_bib31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.preteyeres.2010.01.002","article-title":"Novel aspects of corneal angiogenic and lymphangiogenic privilege","volume":"29","author":"Ellenberg","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2015.04.003_bib32","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1158\/1078-0432.CCR-07-4262","article-title":"Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma","volume":"14","author":"Ellis","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.survophthal.2015.04.003_bib33","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/ar.21096","article-title":"Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer","volume":"293","author":"Feng","year":"2010","journal-title":"Anat Rec (Hoboken)"},{"key":"10.1016\/j.survophthal.2015.04.003_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/sonc.2002.37263","article-title":"Role of angiogenesis in tumor growth and metastasis","volume":"29","author":"Folkman","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1442-9071.2010.02449.x","article-title":"Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab","volume":"39","author":"Fong","year":"2011","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib36","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/IAE.0b013e318042d32c","article-title":"Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: a literature review","volume":"27","author":"Fong","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2015.04.003_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10456-007-9065-1","article-title":"Development of the retinal vasculature","volume":"10","author":"Fruttiger","year":"2007","journal-title":"Angiogenesis"},{"key":"10.1016\/j.survophthal.2015.04.003_bib38","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/S0002-9440(10)63754-6","article-title":"Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells","volume":"164","author":"Galiano","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0079-6123(08)01117-5","article-title":"Modulation of wound healing during and after glaucoma surgery","volume":"173","author":"Georgoulas","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.survophthal.2015.04.003_bib40","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1874364101004010052","article-title":"Aqueous humor dynamics: a review","volume":"4","author":"Goel","year":"2010","journal-title":"Open Ophthalmol J"},{"key":"10.1016\/j.survophthal.2015.04.003_bib41","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.ophtha.2008.06.009","article-title":"Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study","volume":"115","author":"Grewal","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2015.04.003_bib42","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.ophtha.2007.06.028","article-title":"Factors affecting the outcome of trabeculectomy: an analysis based on combined data from two phase III studies of an antibody to transforming growth factor beta2, CAT-152","volume":"114","author":"Grehn","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2015.04.003_bib43","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.ophtha.2007.03.050","article-title":"A\u00a0phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy","volume":"114","author":"Khaw","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2015.04.003_bib44","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.preteyeres.2007.06.001","article-title":"Neovascular glaucoma","volume":"26","author":"Hayreh","year":"2007","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2015.04.003_bib45","first-page":"46","article-title":"Primary open-angle glaucoma: diagnostic approaches and management","volume":"101","author":"Hazin","year":"2009","journal-title":"J\u00a0Natl Med Assoc"},{"key":"10.1016\/j.survophthal.2015.04.003_bib46","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2015.04.003_bib47","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","article-title":"Vascular endothelial growth factor and angiogenesis","volume":"56","author":"Hoeben","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.survophthal.2015.04.003_bib48","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00417-012-2161-y","article-title":"Purified triamcinolone acetonide as antifibrotic adjunct in glaucoma filtering surgery","volume":"251","author":"Hogewind","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib49","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1167\/iovs.07-0878","article-title":"Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery","volume":"48","author":"Honjo","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.04.003_bib50","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1167\/iovs.09-3949","article-title":"Combined treatment with bevacizumab and 5-fluorouracil attenuates the postoperative scarring response after experimental glaucoma filtration surgery","volume":"51","author":"How","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.04.003_bib51","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00061198-200210000-00006","article-title":"Vascular endothelial growth factor is increased in aqueous humor of glaucomatous eyes","volume":"11","author":"Hu","year":"2002","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.survophthal.2015.04.003_bib52","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9440(10)63273-7","article-title":"Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts","volume":"165","author":"Inai","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib53","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ophtha.2011.09.049","article-title":"Outcomes and bleb-related complications of trabeculectomy","volume":"119","author":"Jampel","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2015.04.003_bib54","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1111\/j.1442-9071.2011.02608.x","article-title":"Comparison of the use of 5-fluorouracil and bevacizumab in primary trabeculectomy: results at 1 year","volume":"40","author":"Jurkowska-Dudzinska","year":"2012","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib55","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ajo.2010.03.025","article-title":"Bleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: a pilot study","volume":"150","author":"Kahook","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib56","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ni1013","article-title":"Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins","volume":"5","author":"Karkkainen","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib57","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/annonc\/mdp524","article-title":"Multicentre phase I\/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer","volume":"21","author":"Khasraw","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000334776","article-title":"Enhanced trabeculectomy: the Moorfields Safer Surgery System","volume":"50","author":"Khaw","year":"2012","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib59","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/IJG.0b013e3181895e5c","article-title":"Level of vascular endothelial growth factor in aqueous humor and surgical results of Ahmed glaucoma valve implantation in patients with neovascular glaucoma","volume":"18","author":"Kim","year":"2009","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.survophthal.2015.04.003_bib60","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.ophtha.2013.07.049","article-title":"Trabeculectomy in the 21st century: a multicenter analysis","volume":"120","author":"Kirwan","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2015.04.003_bib61","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s12325-008-0047-5","article-title":"Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma","volume":"25","author":"Kitnarong","year":"2008","journal-title":"Adv Ther"},{"key":"10.1016\/j.survophthal.2015.04.003_bib62","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s00417-006-0321-7","article-title":"Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma","volume":"244","author":"Kiuchi","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib63","doi-asserted-by":"crossref","first-page":"a006502","DOI":"10.1101\/cshperspect.a006502","article-title":"Signal transduction by vascular endothelial growth factor receptors","volume":"2","author":"Koch","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.survophthal.2015.04.003_bib64","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/archophthalmol.2010.350","article-title":"Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series","volume":"129","author":"Kotecha","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib65","first-page":"240","article-title":"[Cyclocryocoagulation in treatment of neovascular glaucoma]","volume":"126","author":"Kovacic","year":"2004","journal-title":"Lijec Vjesn"},{"key":"10.1016\/j.survophthal.2015.04.003_bib66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40123-013-0014-3","article-title":"Vascular endothelial growth factor in anterior chamber liquid patients with diabetic retinopathy, cataract and neovascular glaucoma","volume":"2","author":"Kuzmin","year":"2013","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.survophthal.2015.04.003_bib67","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0039-6257(03)00038-9","article-title":"Antifibrotics and wound healing in glaucoma surgery","volume":"48","author":"Lama","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib68","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00129334-200511000-00013","article-title":"The role of therapeutic angiogenesis in tissue repair and regeneration","volume":"18","author":"Li","year":"2005","journal-title":"Adv Skin Wound Care"},{"key":"10.1016\/j.survophthal.2015.04.003_bib69","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1167\/iovs.08-2662","article-title":"Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery","volume":"50","author":"Li","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.04.003_bib70","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3341\/kjo.2009.23.3.188","article-title":"Concentration of vascular endothelial growth factor after intracameral bevacizumab injection in eyes with neovascular glaucoma","volume":"23","author":"Lim","year":"2009","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib71","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3892\/ijo.2012.1603","article-title":"Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D\/VEGFR-3 with norcantharidin","volume":"41","author":"Liu","year":"2012","journal-title":"Int J Oncol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib72","first-page":"685","article-title":"Level of vascular endothelial growth factor in tenon tissue and results of glaucoma surgery","volume":"130","author":"Lopilly Park","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib73","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1038\/onc.2011.487","article-title":"MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A\/VEGFR2 pathway","volume":"31","author":"Lorenzon","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.survophthal.2015.04.003_bib74","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s00417-013-2428-y","article-title":"Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma\u2014results from a prospective interventional case series","volume":"251","author":"Luke","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib75","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/jid.2014.40","article-title":"Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signaling","volume":"134","author":"McBride","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib76","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.exer.2014.08.005","article-title":"Effects of ranibizumab on the extracellular matrix production by human Tenon's fibroblast","volume":"127","author":"Md Noh","year":"2014","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2015.04.003_bib77","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1167\/iovs.02-0978","article-title":"Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery","volume":"44","author":"Mead","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.04.003_bib78","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1167\/iovs.08-2441","article-title":"Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit","volume":"50","author":"Memarzadeh","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.04.003_bib79","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1586\/erd.10.32","article-title":"Aqueous shunts in the treatment of glaucoma","volume":"7","author":"Mosaed","year":"2010","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.survophthal.2015.04.003_bib80","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.pathol.2.010506.134925","article-title":"VEGF-A and the induction of pathological angiogenesis","volume":"2","author":"Nagy","year":"2007","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib81","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/mt.2012.234","article-title":"Adipose-derived stromal cells overexpressing vascular endothelial growth factor accelerate mouse excisional wound healing","volume":"21","author":"Nauta","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.survophthal.2015.04.003_bib82","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ajo.2011.08.005","article-title":"Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy","volume":"153","author":"Nilforushan","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib83","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1167\/iovs.10-5669","article-title":"Antifibrotic activity of bevacizumab on human Tenon's fibroblasts in\u00a0vitro","volume":"51","author":"O'Neill","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.04.003_bib84","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/02713683.2013.851704","article-title":"The effect of bevacizumab on wound healing modulation in an experimental trabeculectomy model","volume":"39","author":"Ozgonul","year":"2014","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2015.04.003_bib85","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10456-011-9249-6","article-title":"Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab","volume":"15","author":"Papadopoulos","year":"2012","journal-title":"Angiogenesis"},{"key":"10.1016\/j.survophthal.2015.04.003_bib86","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/eye.2008.88","article-title":"Anti-VEGF therapy: comparison of current and future agents","volume":"22","author":"Pieramici","year":"2008","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2015.04.003_bib87","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/01.RES.0000057997.77714.72","article-title":"VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism","volume":"92","author":"Pipp","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.survophthal.2015.04.003_bib88","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11481-014-9531-7","article-title":"Vascular endothelial growth factor signaling in hypoxia and inflammation","volume":"9","author":"Ramakrishnan","year":"2014","journal-title":"J\u00a0Neuroimmune Pharmacol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2011.07.005","article-title":"The changing conceptual basis of trabeculectomy: a review of past and current surgical techniques","volume":"57","author":"Razeghinejad","year":"2012","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib90","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0161-6420(01)00885-5","article-title":"Randomized controlled clinical trial of beta irradiation as an adjunct to trabeculectomy in open-angle glaucoma","volume":"109","author":"Rehman","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2015.04.003_bib91","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1242\/jcs.114.5.853","article-title":"The splice variants of vascular endothelial growth factor (VEGF) and their receptors","volume":"114","author":"Robinson","year":"2001","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.survophthal.2015.04.003_bib92","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1158\/0008-5472.CAN-03-2581","article-title":"Loss of vascular endothelial growth factor a activity in murine epidermal keratinocytes delays wound healing and inhibits tumor formation","volume":"64","author":"Rossiter","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.survophthal.2015.04.003_bib93","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1097\/IJG.0000000000000008","article-title":"Risk factors for adverse consequences of low intraocular pressure after trabeculectomy","volume":"23","author":"Saeedi","year":"2014","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.survophthal.2015.04.003_bib94","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1755-3768.2009.01648.x","article-title":"Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma","volume":"88","author":"Saito","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib95","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.2007.14.9930","article-title":"Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study","volume":"26","author":"Saltz","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib96","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00055735-200404000-00011","article-title":"Current management of glaucoma","volume":"15","author":"Schwartz","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib97","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2174\/15665240113139990021","article-title":"Novel insight into the inflammatory and cellular responses following experimental glaucoma surgery: a roadmap for inhibiting fibrosis","volume":"13","author":"Seet","year":"2013","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.survophthal.2015.04.003_bib98","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.survophthal.2012.01.008","article-title":"Wound modulation after filtration surgery","volume":"57","author":"Seibold","year":"2012","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib99","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/IJG.0b013e31821826b2","article-title":"Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial","volume":"21","author":"Sengupta","year":"2012","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.survophthal.2015.04.003_bib100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jb\/mvs136","article-title":"Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases","volume":"153","author":"Shibuya","year":"2013","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.survophthal.2015.04.003_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4062\/biomolther.2013.113","article-title":"VEGF-VEGFR signals in health and disease","volume":"22","author":"Shibuya","year":"2014","journal-title":"Biomol Ther (Seoul)"},{"issue":"10","key":"10.1016\/j.survophthal.2015.04.003_bib102","first-page":"CD007920","article-title":"Anti-vascular endothelial growth factor for neovascular glaucoma","author":"Simha","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.survophthal.2015.04.003_bib103","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0161-6420(01)00775-8","article-title":"Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma","volume":"108","author":"Sivak-Callcott","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2015.04.003_bib104","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00061198-200106000-00001","article-title":"The use of antimetabolites with trabeculectomy: a critical appraisal","volume":"10","author":"Spaeth","year":"2001","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.survophthal.2015.04.003_bib105","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1089\/jop.2012.0250","article-title":"The effect of bevacizumab on the outcome of trabeculectomy with 5-fluorouracil","volume":"29","author":"Suh","year":"2013","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.survophthal.2015.04.003_bib106","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/BOR.0b013e328337c95a","article-title":"Angiogenesis and vasculogenesis in rheumatoid arthritis","volume":"22","author":"Szekanecz","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib107","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1167\/iovs.11-7478","article-title":"Effects of trehalose on VEGF-stimulated angiogenesis and myofibroblast proliferation: implications for glaucoma filtration surgery","volume":"52","author":"Takeuchi","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.04.003_bib108","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.exer.2010.07.002","article-title":"Inhibitory effects of trehalose on fibroblast proliferation and implications for ocular surgery","volume":"91","author":"Takeuchi","year":"2010","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2015.04.003_bib109","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/ATVBAHA.107.158022","article-title":"The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes","volume":"28","author":"Tchaikovski","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib110","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2015.04.003_bib111","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.exer.2011.08.016","article-title":"The role of different VEGF isoforms in scar formation after glaucoma filtration surgery","volume":"93","author":"Van Bergen","year":"2011","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2015.04.003_bib112","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/bjophthalmol-2013-303966","article-title":"Intracameral bevacizumab as an adjunct to trabeculectomy: a 1-year prospective, randomised study","volume":"98","author":"Vandewalle","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib113","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/jop.2009.0036","article-title":"Intravitreal bevacizumab for neovascular glaucoma","volume":"25","author":"Vasudev","year":"2009","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.survophthal.2015.04.003_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2013.11.002","article-title":"Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning","volume":"25","author":"Vempati","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.survophthal.2015.04.003_bib115","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000358600","article-title":"Topical bevacizumab for neovascular glaucoma: a pilot study","volume":"93","author":"Waisbourd","year":"2014","journal-title":"Pharmacology"},{"key":"10.1016\/j.survophthal.2015.04.003_bib116","doi-asserted-by":"crossref","first-page":"e91355","DOI":"10.1371\/journal.pone.0091355","article-title":"Low-intensity vibration improves angiogenesis and wound healing in diabetic mice","volume":"9","author":"Weinheimer-Haus","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.survophthal.2015.04.003_bib117","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/archopht.1963.00960040310007","article-title":"Neovascular gluacoma complicating carotid-cavernous fistula","volume":"69","author":"Weiss","year":"1963","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib118","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/labinvest.2008.36","article-title":"Regulation of scar formation by vascular endothelial growth factor","volume":"88","author":"Wilgus","year":"2008","journal-title":"Lab Invest"},{"issue":"4","key":"10.1016\/j.survophthal.2015.04.003_bib119","first-page":"CD002897","article-title":"Intra-operative mitomycin C for glaucoma surgery","author":"Wilkins","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.survophthal.2015.04.003_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1350-9462(02)00043-5","article-title":"Vascular endothelial growth factors and angiogenesis in eye disease","volume":"22","author":"Witmer","year":"2003","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2015.04.003_bib121","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11060-014-1503-5","article-title":"Hypoxia inducible factor-1 is involved in growth factor, glucocorticoid and hypoxia mediated regulation of vascular endothelial growth factor-A in human meningiomas","volume":"119","author":"Wu","year":"2014","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib122","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1586\/era.10.171","article-title":"Potential role of soluble VEGFR-1 in antiangiogenesis therapy for cancer","volume":"11","author":"Yang","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.survophthal.2015.04.003_bib123","first-page":"788","article-title":"Local injection of pulp cells enhances wound healing during the initial proliferative phase through the stimulation of host angiogenesis","volume":"39","author":"Yang","year":"2013","journal-title":"J\u00a0Endod"},{"key":"10.1016\/j.survophthal.2015.04.003_bib124","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2009.24.2669","article-title":"Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial","volume":"28","author":"Yao","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.survophthal.2015.04.003_bib125","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/IJG.0b013e3181997211","article-title":"Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial","volume":"18","author":"Yazdani","year":"2009","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.survophthal.2015.04.003_bib126","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/mt.2014.53","article-title":"Multicenter randomized phase 2 clinical trial of a recombinant human endostatin adenovirus in patients with advanced head and neck carcinoma","volume":"22","author":"Ye","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.survophthal.2015.04.003_bib127","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1073\/pnas.0813061106","article-title":"VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.survophthal.2015.04.003_bib128","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/A:1021540120521","article-title":"A\u00a0monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR\/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model","volume":"5","author":"Zhang","year":"2002","journal-title":"Angiogenesis"},{"key":"10.1016\/j.survophthal.2015.04.003_bib129","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1167\/iovs.12-11507","article-title":"Levels of erythropoietin and vascular endothelial growth factor in surgery-required advanced neovascular glaucoma eyes before and after intravitreal injection of bevacizumab","volume":"54","author":"Zhou","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625715000703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625715000703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:41:08Z","timestamp":1758541268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625715000703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":129,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0039625715000703"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2015.04.003","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2015.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}